Cargando…

Lipoprotein(a) concentrations in acute myocardial infarction patients are not indicative of levels at six month follow-up

AIMS: Lipoprotein(a) [Lp(a)] levels are generally constant throughout an individual’s lifetime, and current guidelines recommend that a single measurement is sufficient to assess the risk of coronary artery disease (CAD). However, it is unclear whether a single measurement of Lp(a) in individuals wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ziogos, Efthymios, Vavuranakis, Michael A, Harb, Tarek, Foran, Palmer L, Blaha, Michael J, Jones, Steven R, Lai, Shenghan, Gerstenblith, Gary, Leucker, Thorsten M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10122422/ https://www.ncbi.nlm.nih.gov/pubmed/37095769 http://dx.doi.org/10.1093/ehjopen/oead035

Ejemplares similares

Effect of Sex on Coronary Endothelial Dysfunction in People Living With HIV
por: Minhas, Anum S., et al.
Publicado: (2022)

High-density lipoprotein and endothelial function in patients with myocardial infarction: Pieces in a puzzle
por: Martin, Seth S., et al.
Publicado: (2014)

Coronary Endothelial Dysfunction Is Associated With Elevated Serum PCSK9 Levels in People With HIV Independent of Low‐Density Lipoprotein Cholesterol
por: Leucker, Thorsten M., et al.
Publicado: (2018)

Evolocumab, a PCSK9‐Monoclonal Antibody, Rapidly Reverses Coronary Artery Endothelial Dysfunction in People Living With HIV and People With Dyslipidemia
por: Leucker, Thorsten M., et al.
Publicado: (2020)

Lipids, Lipoproteins, and Metabolites and Risk of Myocardial Infarction and Stroke
por: Holmes, Michael V., et al.
Publicado: (2018)

Potential of lipoproteins as biomarkers in acute myocardial infarction
por: Khan, Haseeb Ahmad, et al.
Publicado: (2017)

Narrowing Sex Differences in Lipoprotein Cholesterol Subclasses Following Mid‐Life: The Very Large Database of Lipids (VLDL‐10B)
por: Swiger, Kristopher J., et al.
Publicado: (2014)

Low High-Density Lipoprotein and Risk of Myocardial Infarction
por: Ramirez, A., et al.
Publicado: (2015)

Heart rate variability and incidence of depression during the first six months following first myocardial infarction
por: Wilkowska, Alina, et al.
Publicado: (2019)

Positron Emission Tomography-Determined Hyperemic Flow, Myocardial Flow Reserve, and Flow Gradient—Quo Vadis?
por: Leucker, Thorsten M., et al.
Publicado: (2017)

Ability of extracellular volume imaging to serially measure infarct size compared to LGE within six months after acute myocardial infarction
por: Sinn, Martin R, et al.
Publicado: (2015)

Arrhythmia in Acute Myocardial Infarction: A Six-Month Retrospective Analysis From the National Institute of Cardiovascular Diseases
por: Mueed, Abdul, et al.
Publicado: (2020)

Effect of COVID-19 pandemic on six-month mortality and clinical outcomes of patients with ST-elevation myocardial infarction
por: Zahid, Basant, et al.
Publicado: (2022)

Serum lipoprotein levels in takotsubo cardiomyopathy vs. myocardial infarction
por: Gaddam, Sainath, et al.
Publicado: (2011)

Lipoprotein (a) and myocardial infarction: impact on long-term mortality
por: Zhang, Jian, et al.
Publicado: (2023)

Myocardial ATP depletion detected noninvasively predicts sudden cardiac death risk in patients with heart failure
por: Samuel, T. Jake, et al.
Publicado: (2022)

Roles of High-Density Lipoprotein Cholesterol in Patients With Acute Myocardial Infarction
por: Lee, Cheol Hyun, et al.
Publicado: (2016)

Impact of thrombus aspiration during ST-Elevation Myocardial Infarction: a six month composite endpoint and risk of stroke analyses of the TASTE trial
por: Olivecrona, Göran K, et al.
Publicado: (2016)

Sudden death six weeks after a myocardial infarct.
por: Lee, F., et al.
Publicado: (1988)

Effectiveness of sertraline in treatment of depression in a consecutive sample of patients with acute myocardial infarction: six month prospective study on outcome
por: Mohapatra, Prasanta Kumar, et al.
Publicado: (2005)

Recurrent intraventricular thrombus six months after ST-elevation myocardial infarction in a diabetic man: a case report
por: Lacalzada, Juan, et al.
Publicado: (2013)

In-hospital and six-month outcomes of elderly patients undergoing primary percutaneous coronary intervention for acute ST-elevation myocardial infarction
por: Noohi, Fereydoon, et al.
Publicado: (2016)

Six-Month Outcomes for COVID-19 Negative Patients with Acute Myocardial Infarction Before Versus During the COVID-19 Pandemic
por: Aldujeli, Ali, et al.
Publicado: (2021)

Six-Month Outcomes for COVID-19-Negative Patients With Acute Myocardial Infarction Before Versus During the COVID-19 Pandemic
por: Aldujeli, Ali, et al.
Publicado: (2022)

Non-high-density lipoprotein cholesterol predicts nonfatal recurrent myocardial infarction in patients with ST segment elevation myocardial infarction
por: Gao, Ming, et al.
Publicado: (2017)

Predictive and protective role of high-density lipoprotein cholesterol in acute myocardial infarction
por: Park, Jin Sup, et al.
Publicado: (2019)

Frailty Among Older Adults With Acute Myocardial Infarction and Outcomes From Percutaneous Coronary Interventions
por: Damluji, Abdulla A., et al.
Publicado: (2019)

Non-high density lipoprotein cholesterol versus low density lipoprotein cholesterol as a discriminating factor for myocardial infarction
por: Sigdel, Manoj, et al.
Publicado: (2012)

Elevated lipoprotein (a) levels are associated with the acute myocardial infarction in patients with normal low-density lipoprotein cholesterol levels
por: Cai, Gaojun, et al.
Publicado: (2019)

CRT-100.96 Effect of COVID-19 Pandemic on Six-Month Mortality and Clinical Outcomes of Patients With ST-Elevation Myocardial Infarction
por: Elakabawi, Karim, et al.
Publicado: (2023)

A prospective study of the impact of serial troponin measurements on the diagnosis of myocardial infarction and hospital and six-month mortality in patients admitted to ICU with non-cardiac diagnoses
por: Ostermann, Marlies, et al.
Publicado: (2014)

Ambient Air Pollution and Lipoprotein-Associated Phospholipase A(2) in Survivors of Myocardial Infarction
por: Brüske, Irene, et al.
Publicado: (2011)

Lipoprotein(a): An independent, genetic, and causal factor for cardiovascular disease and acute myocardial infarction
por: Enas, Enas A., et al.
Publicado: (2019)

Changes in lipoproteins associated with lipid-lowering and antiplatelet strategies in patients with acute myocardial infarction
por: Lotfollahi, Zahra, et al.
Publicado: (2022)

Lipoprotein subfraction profiling in the search of new risk markers for myocardial infarction: The HUNT study
por: Sperstad, Sigri Bakken, et al.
Publicado: (2023)

A Systematic Review on the Risk Modulators of Myocardial Infarction in the “Young”—Implications of Lipoprotein (a)
por: Stătescu, Cristian, et al.
Publicado: (2023)

The Impact of Social Determinants of Health and Lifestyle on the Association of Lipoprotein(a) with Myocardial Infarction and Stroke
por: Brandt, Eric J., et al.
Publicado: (2023)

Pulmonary and systemic hemodynamics are associated with myocardial injury in the acute respiratory distress syndrome
por: Metkus, Thomas S, et al.
Publicado: (2020)

Clinical and angiographic profiles and six months outcomes of smokers with acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary angioplasty
por: Gupta, A., et al.
Publicado: (2018)

Variants Tagging LGALS-3 Haplotype Block in Association with First Myocardial Infarction and Plasma Galectin-3 Six Months after the Acute Event
por: Djordjevic, Ana, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tg5l30o08uoftvujjoedngk1ko